Potential biomarker of brain response to opioid antagonism in adolescents with eating disorders: a pilot study

BACKGROUND: Eating Disorders (ED) affect up to 5% of youth and are associated with reward system alterations and compulsive behaviors. Naltrexone, an opioid antagonist, is used to treat ED behaviors such as binge eating and/or purging. The presumed mechanism of action is blockade of reward activatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Stancil, Stephani L., Yeh, Hung-Wen, Brucks, Morgan G., Bruce, Amanda S., Voss, Michaela, Abdel-Rahman, Susan, Brooks, William M., Martin, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363723/
https://www.ncbi.nlm.nih.gov/pubmed/37492067
http://dx.doi.org/10.3389/fpsyt.2023.1161032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363723/
https://www.ncbi.nlm.nih.gov/pubmed/37492067
http://dx.doi.org/10.3389/fpsyt.2023.1161032

Ejemplares similares